These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9207744)

  • 1. Trypanosoma cruzi: resistance to the pore forming protein of cytotoxic lymphocytes--perforin.
    Bisaggio Rda C; de Castro SL; Barbosa HS; Brandão Cde A; Persechini PM
    Exp Parasitol; 1997 Jun; 86(2):144-54. PubMed ID: 9207744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraflagellar rod protein-specific CD8+ cytotoxic T lymphocytes target Trypanosoma cruzi-infected host cells.
    Wrightsman RA; Luhrs KA; Fouts D; Manning JE
    Parasite Immunol; 2002 Aug; 24(8):401-12. PubMed ID: 12406194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
    Nickell SP; Sharma D
    Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.
    Silverio JC; de-Oliveira-Pinto LM; da Silva AA; de Oliveira GM; Lannes-Vieira J
    Int J Exp Pathol; 2010 Feb; 91(1):72-86. PubMed ID: 19878357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi.
    Kumar S; Tarleton RL
    Parasite Immunol; 1998 May; 20(5):207-16. PubMed ID: 9651921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites.
    Dotiwala F; Mulik S; Polidoro RB; Ansara JA; Burleigh BA; Walch M; Gazzinelli RT; Lieberman J
    Nat Med; 2016 Feb; 22(2):210-6. PubMed ID: 26752517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms.
    Lieke T; Graefe SE; Klauenberg U; Fleischer B; Jacobs T
    Infect Immun; 2004 Dec; 72(12):6817-25. PubMed ID: 15557602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice.
    Tzelepis F; de Alencar BC; Penido ML; Gazzinelli RT; Persechini PM; Rodrigues MM
    Infect Immun; 2006 Apr; 74(4):2477-81. PubMed ID: 16552083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a perforin-mediated mechanism controlling cardiac inflammation in Trypanosoma cruzi infection.
    Henriques-Pons A; Oliveira GM; Paiva MM; Correa AF; Batista MM; Bisaggio RC; Liu CC; Cotta-De-Almeida V; Coutinho CM; Persechini PM; Araujo-Jorge TC
    Int J Exp Pathol; 2002 Apr; 83(2):67-79. PubMed ID: 12084043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid loss of perforin and serine protease RNA in cytotoxic lymphocytes exposed to sensitive targets.
    Bajpai A; Kwon BS; Brahmi Z
    Immunology; 1991 Oct; 74(2):258-63. PubMed ID: 1721042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concerted action of perforin and granzymes is critical for the elimination of Trypanosoma cruzi from mouse tissues, but prevention of early host death is in addition dependent on the FasL/Fas pathway.
    Müller U; Sobek V; Balkow S; Hölscher C; Müllbacher A; Museteanu C; Mossmann H; Simon MM
    Eur J Immunol; 2003 Jan; 33(1):70-8. PubMed ID: 12594834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells.
    Lehmann C; Zeis M; Schmitz N; Uharek L
    Blood; 2000 Jul; 96(2):594-600. PubMed ID: 10887123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane channel formation by the lymphocyte pore-forming protein: comparison between susceptible and resistant target cells.
    Persechini PM; Young JD; Almers W
    J Cell Biol; 1990 Jun; 110(6):2109-16. PubMed ID: 1693622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antimicrobial activity of cytolytic T cells mediated by granulysin.
    Stenger S; Hanson DA; Teitelbaum R; Dewan P; Niazi KR; Froelich CJ; Ganz T; Thoma-Uszynski S; Melián A; Bogdan C; Porcelli SA; Bloom BR; Krensky AM; Modlin RL
    Science; 1998 Oct; 282(5386):121-5. PubMed ID: 9756476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
    Jiang S; Persechini PM; Perussia B; Young JD
    J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.
    Kafrouni MI; Brown GR; Thiele DL
    J Immunol; 2001 Aug; 167(3):1566-74. PubMed ID: 11466378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenospecific cytotoxic T lymphocytes: potent lysis in vitro and in vivo.
    Smyth MJ; Kershaw MH; Trapani JA
    Transplantation; 1997 Apr; 63(8):1171-8. PubMed ID: 9133481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Killing of cells by perforin. Resistance to killing is not due to diminished binding of perforin to the cell membrane.
    Jones J; Morgan BP
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):199-204. PubMed ID: 1741748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis.
    Reiter Y; Ciobotariu A; Jones J; Morgan BP; Fishelson Z
    J Immunol; 1995 Aug; 155(4):2203-10. PubMed ID: 7636268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.